The company, which is a graduate of the Naiot incubator has developed a catheter device to treat vascular occlusions.
Sources inform ''Globes'' that EndoCross Ltd., which has developed a catheter device to treat vascular occlusions, has raised $2.5 million from Ofer Hi Tech Ltd.. Viola Private Equity, which is controlled by Shlomo and Aharon Dovrat, and Harel Beit-On, also participated in the funding round. Endocross also raised seed funding from Ofer Hi Tech's incubator Naiot Venture Accelerator.
Endocross was founded in 2005 by Eran Hirszowicz and CEO Eran Levit. The company has developed a catheter, which enables surgeons to rapidly open blocked coronary vessels. The product has already been trialed successfully on humans, and, according to Levit, "the feedback we received from surgeons was surprisingly positive. We were expecting surgeons to welcome the results of the clinical trials, but we also received feedback from people who enthused about how easy it is to use, and the fact that one can learn to operate it in minutes."
Published by Globes [online], Israel business news - www.globes-online.com - on November 24, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008